Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

You’ve decided to invest in Anavex knowing that it’s a speculative biotech and that you could lose your investment. I don’t have an issue with that. Good luck. But normalizing Missling and basically saying he’s no different than other biotech CEOs, or blaming Adam Feuerstein and hedge funds, is wrong. Missling’s track record, which I’ve urged you to spend some time reviewing, is not just like any other CEO. Confirmation bias to justify an investment is a recipe to lose money. Please do yourself a favor and study Missling’s work history prior to Anavex and his track record since joining Anavex. If you look over his work history you’ll see that he rarely spent more than a year in any job. He was also a senior executive at an investment bank that was shut down by the SEC. In some instances he lasted just a few months. Don’t take my word for it. You can Google it. With some effort, you’ll find it. If you do that, I think you will see that Missling is at the tail end of the bell curve when it comes to CEO performance. It’s one of the reasons I believe he should be replaced.

Again, I’m not saying don’t invest. I’m simply telling you to at least get a clearer picture of who you’ve entrusted with your money.